Experienced in Chronic Inflammatory Demyelinating Polyneuropathy

Katrin Hahn

Berlin, BE, DE 
Experienced in Chronic Inflammatory Demyelinating Polyneuropathy
Berlin, BE, DE 
OverviewLocationsClinical Research

Overview

Katrin Hahn practices in Berlin, Germany. Ms. Hahn is rated as an Experienced expert by MediFind in the treatment of Chronic Inflammatory Demyelinating Polyneuropathy. Her top areas of expertise are Familial Transthyretin Amyloidosis, Transthyretin Amyloidosis, Cardiac Amyloidosis, and Primary Amyloidosis.

Her clinical research consists of co-authoring 64 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 4 articles in the study of Chronic Inflammatory Demyelinating Polyneuropathy.

Gender
Female

Locations

Berlin, BE 10117, Germany
Other Locations
Mitte, BE, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Genetic Screening of an At-risk Population for Hereditary TransthyRetin-related AMyloidosis and Longitudinal Monitoring of TTR Positive Subjects- A Multicenter Epidemiological Longitudinal Protocol
Genetic Screening of an At-risk Population for Hereditary TransthyRetin-related AMyloidosis and Longitudinal Monitoring of TTR Positive Subjects- A Multicenter Epidemiological Longitudinal Protocol
Enrollment Status: Completed
Publish Date: June 29, 2025
Screening for Amyloidosis Before Aortic Valve Elective Replacement (SAVER)
Screening for Amyloidosis Before Aortic Valve Elective Replacement (SAVER)
Enrollment Status: Active_not_recruiting
Publish Date: February 12, 2025
Intervention Type: Other
A Multicenter, Prospective, Randomized, Placebo-controlled, Double-blind, Parallel-group Clinical Trial to Assess the Efficacy and Safety of Immune Globulin Intravenous (Human) Flebogamma® 5% DIF in Patients With Post-Polio Syndrome
A Multicenter, Prospective, Randomized, Placebo-controlled, Double-blind, Parallel-group Clinical Trial to Assess the Efficacy and Safety of Immune Globulin Intravenous (Human) Flebogamma® 5% DIF in Patients With Post-Polio Syndrome
Enrollment Status: Terminated
Publish Date: November 27, 2023
Intervention Type: Drug, Biological
Study Drug: Flebogamma
Study Phase: Phase 2/Phase 3
View 2 Less Clinical Trials

64 Total Publications

Real-world treatment management in hereditary transthyretin amyloidosis - an experience report and proposal for therapy switch decision criteria.
Real-world treatment management in hereditary transthyretin amyloidosis - an experience report and proposal for therapy switch decision criteria.
Journal: Neurological research and practice
Published: July 16, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Hahn's expertise for a condition
ConditionClose
    View All 33 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile